ARTICLE | Company News
MorphoSys receives milestone from GPC
September 25, 2000 7:00 AM UTC
MorphoSys (NMarkt:MOR) received a milestone payment from GPC Biotech (NMarkt:GPC)under the companies' 1999 agreement to develop human antibodies against GPC's MHC class II targets to treat transplant ...